The voice of Utah’s life sciences community

Medical Devices

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

BioUtah is the common voice and flag bearer for Utah’s life sciences industry, comprised of medical devices, pharmaceuticals, diagnostics, laboratories, research facilities, and biotechnology of all types. BioUtah connects industry with government, academia, capital markets, media, and service providers. Together we form an ecosystem that fosters collaboration, promotes innovation, and delivers technology that saves lives.

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

2026 Biosphere Magazine Now Available

BioUtah's 2026 Biosphere magazine spotlights the innovators, companies, and milestones shaping Utah's life sciences industry — from early-stage startups to global acquisitions.

BIO Business Solutions

Savings achieved through this program on lab supplies, equipment, shipping and much more, often exceed the annual cost membership in BioUtah.

Bill Tracker

With the Utah legislature in session, follow the bills BioUtah is tracking that affect the life sciences industry.

Featured New Member

SLCC serves nearly 50k students across 8 campuses, offers online classes, and hosts the most diverse student body in Utah.

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

September 24, 2026

bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies

September 24, 2026

Priority Review Granted for PolarityBio’s SkinTE for Treatment of Diabetic Foot Ulcers

PDUFA target date set for March 16, 2027, following positive phase 3 results

September 24, 2026

National Institutes of Health Award Inherent Biosciences a Direct-to-Phase II SBIR Grant

September 24, 2026

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

Roundtable discussion, taking place in New York City, will examine the ongoing Ebola outbreak and technologies needed to strengthen future outbreak response.

September 24, 2026

Epitel’s REMI Neuro Monitoring System Selected for the FDA’s READI-Home Innovation Challenge

September 24, 2026

Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization

Financing provides capital to advance Freyya’s technology through the next regulatory milestones and toward building a foundation for commercialization.

September 23, 2026

FROM LAB TO LIVING ROOM: REVOLUTIONARY UTAH BIONIC ARM ENTERS FIRST HOME TRIAL

PARTICIPANT TESTS DIRECT NERVE INTERFACE OF THOUGHT-CONTROLLED “LUKE ARM” AT HOME

September 17, 2026

BioUtah Member Appreciation BBQ 2026 Recap

Thanks to all who joined us andt sponsored the event! Be sure to check out our event gallery!

More BioUtah News